The development component of the UCSD CFAR is designed to facilitate and encourage new investigators and new ideas in HIV and AIDS research. The intent is to optimize opportunities for productive research by providing immediate financial support in association with resource support provided by the core facilities. Three categories of developmental grants will be supported although, the number and type of these categories are flexible. Presently, the three categories are: 1) Investigators new to AIDS research; 2) Feasibility studies and 3) Evolving research opportunities. Requests for submission of developmental grants will be advertised through the Administrative Core twice a year, for funding in January and June. The submissions are evaluated by a review committee which has an evolving membership. Additional members from related fields will be added as applications for developmental funds become increasingly diverse in scope. Merit is the driving criterion for making the awards; however, fostering the development of junior and minority investigators are two important programmatic goals which are also considered in the prioritization of awards. The amount of the awards given will be increased to $35,000. As part of their awards, investigators are required to provide documentation of publications and peer reviewed funding that results from the developmental awards. They are also required to cite CFAR support in publications which are generated or related to the research performed using CFAR developmental funds. With the growth of the CFAR, we anticipate a greater number of innovative and timely projects will be funded, attracting new members and affiliates who can advance HIV and AIDS research, supported, in part, by developmental funds.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI036214-06
Application #
6268175
Study Section
Project Start
1998-09-01
Project End
1999-02-28
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dinesha, T R; Boobalan, J; Sivamalar, S et al. (2018) Occult HBV infection in HIV-infected adults and evaluation of pooled NAT for HBV. J Viral Hepat 25:718-723
Fraser, Hannah; Zibbell, Jon; Hoerger, Thomas et al. (2018) Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic. Addiction 113:173-182
Dinesha, Thongadi Ramesh; Boobalan, Jayaseelan; Sivamalar, Sathasivam et al. (2018) HIV, Hepatitis B Virus, and Hepatitis C Virus Prevalence Among High-Risk Populations in South India. AIDS Res Hum Retroviruses 34:327-328
Steinhardt, James J; Guenaga, Javier; Turner, Hannah L et al. (2018) Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity. Nat Commun 9:877
Thaney, Victoria E; Sanchez, Ana B; Fields, Jerel A et al. (2018) Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research. J Neurovirol 24:156-167
Stecher, Melanie; Hoenigl, Martin; Eis-Hübinger, Anna Maria et al. (2018) Hotspots of Transmission Driving the Local Hiv Epidemic in the Cologne-Bonn Region, Germany. Clin Infect Dis :
Hoenigl, Martin; Jain, Sonia; Moore, David et al. (2018) Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1. Emerg Infect Dis 24:
Lin, Timothy C; Dijkstra, Maartje; De Bree, Godelieve J et al. (2018) Brief Report: The Amsterdam Symptom and Risk-Based Score Predicts for Acute HIV Infection in Men Who Have Sex With Men in San Diego. J Acquir Immune Defic Syndr 79:e52-e55
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887

Showing the most recent 10 out of 921 publications